A long-term neuropsychological evaluation in Fabry disease

被引:0
|
作者
G. Loret
M. Miatton
G. Vingerhoets
B. Poppe
D. Hemelsoet
机构
[1] Ghent University Hospital,Department of Neurology
[2] Ghent University,Department of Experimental Psychology
[3] Ghent University Hospital,Center for Medical Genetics
来源
Acta Neurologica Belgica | 2021年 / 121卷
关键词
Fabry disease; Cognition; Memory; Neuropsychology;
D O I
暂无
中图分类号
学科分类号
摘要
Fabry disease (FD) is a X-linked multi-systemic metabolic disorder with mainly renal, cardiac and neurological dysfunction. The neuropsychological impact is still unclear, with previous study results ranging from disturbance of speed of information processing and executive functions to a normal cognitive profile. The aim of our study was to gain further insight into the neuropsychological involvement of FD. Patients with genetically proven FD were enrolled at the Ghent University Hospital by their treating neurologist. We evaluated the cognitive status of each patient by a thorough neuropsychological test battery and these exact same neuropsychological assessments were repeated after a follow-up period of 2–4 years and at a second follow-up moment 1–4 years after the first follow-up. Thirteen patients with FD were included (8 female) with mean age of 41.5 years (SD ± 13.9) at baseline. All patients had normal neuropsychological test results on the subtests included in the cognitive battery at baseline, according to age-, gender- and education matched normative data. At the first follow-up moment (2–4 years after baseline), six patients were included (3 male), mean age 45.3 years. At the second follow-up (1–4 years after first follow-up), four patients (2 male) were included, with mean age 45 years. Both at the first and second follow-up moments, all patients obtained normal scores on the subtests. The cognitive functioning appeared to be in the normal range at baseline and did not decline over a follow-up period of 3–8 years, suggesting that cognition in FD patients may be well-preserved in time.
引用
收藏
页码:191 / 197
页数:6
相关论文
共 50 条
  • [31] Long-term neuropsychological sequelae of severe burns
    Varney, NR
    Ju, DS
    Shepherd, JS
    Kealey, GP
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1998, 13 (08) : 737 - 749
  • [32] Long-Term Neuropsychological Deficits in Concussed Athletes
    Souissi, Sofiane
    Bellaj, Tarek
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2016, 51 : 870 - 870
  • [33] LONG-TERM NEUROPSYCHOLOGICAL EFFECTS OF SATURATION DIVING
    KLOVE, H
    VAERNES, RJ
    ELLERTSEN, B
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1991, 13 (03) : 439 - 440
  • [34] Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease
    Skrunes, Rannveig
    Tondel, Camilla
    Leh, Sabine
    Larsen, Kristin Kampevold
    Houge, Gunnar
    Davidsen, Einar Skulstad
    Hollak, Carla
    van Kuilenburg, Andre B. P.
    Vaz, Frederic M.
    Svarstad, Einar
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (09): : 1470 - 1479
  • [35] A MULTICENTER STUDY OF LONG-TERM ENZYME REPLACEMENT THERAPY IN PATIENTS WITH FABRY DISEASE IN GREECE
    Andrikos, A.
    Iatrou, Ch.
    Boletis, J. N.
    Diamandopoulos, A.
    Pappas, M.
    Kalaitzidis, K.
    Katsinas, Ch.
    Balafa, O.
    Revela, I.
    Dimitroula, V.
    Drakoulogona, O.
    Ouzouni, A.
    Siamopoulos, K. C.
    CLINICAL THERAPEUTICS, 2009, 31 : S39 - S39
  • [36] Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy
    Pierre, Monney
    Salah, Qanadli D.
    Steven, Hajdu D.
    Christel, Tran
    Juerg, Schwitter
    Olivier, Dormond
    Frederic, Barbey
    SWISS MEDICAL WEEKLY, 2017, 147
  • [37] Long-Term Efficacy of Migalastat on Renal Function and Outcomes in Patients with Fabry Disease (FD)
    Bichet, Daniel G.
    Feldt-Rasmussen, Ulla
    Giugliani, Roberto
    Hughes, Derralynn
    Krusinska, Eva
    Veleva-Rotse, Biliana O.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 420 - 421
  • [38] Long-term benefit of enzyme replacement therapy on cardiac manifestation in Japanese Fabry disease
    Anan, I.
    Hongo, K.
    Ito, K.
    Kawai, M.
    Taniguchi, I.
    Yoshimura, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 231 - 232
  • [39] Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease
    Tolar, J.
    Petryk, A.
    Khan, K.
    Bjoraker, K. J.
    Jessurun, J.
    Dolan, M.
    Kivisto, T.
    Charnas, L.
    Shapiro, E. G.
    Orchard, P. J.
    BONE MARROW TRANSPLANTATION, 2009, 43 (01) : 21 - 27
  • [40] Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease
    J Tolar
    A Petryk
    K Khan
    K J Bjoraker
    J Jessurun
    M Dolan
    T Kivisto
    L Charnas
    E G Shapiro
    P J Orchard
    Bone Marrow Transplantation, 2009, 43 : 21 - 27